Asakage et al
Fasting glucose levels consistently below 70 mg/dL, or symptoms like shakiness, confusion, and sweating, should prompt a blood glucose check and medication adjustment discussion
Dulaglutide use was associated with a 64% lower risk of OUD (OR = 0.36, 95% CI: 0.20-0.64, p = 0.0006) ( Figure 2 )
Why Weight Loss Plateaus on Semaglutide (Ozempic and Wegovy) A weight loss plateau is when progress slows down or stops, even though someone is still following their treatment and healthy habits
Noktrnal hipoglisemi riskini azaltr
In 2023, a major trial reported that weekly semaglutide significantly lowered the risk of heart attack, stroke, or cardiac death in overweight/obese individuals without diabetes, likely because of the combined weight loss and direct metabolic effects